Cervical disc device outperforms fusion in FDA trial

Synergy Spine's Synergy Disc, a motion-preserving cervical disc replacement device, reached 100 implants in 100 days following FDA approval and demonstrated clinical superiority to fusion in its IDE trial with an 87.1% success rate at 24 months.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.